Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. The Percutaneous Transluminal Angioplasty (PTA) Balloon Catheters includes Percutaneous Transluminal Angioplasty (PTA) Standard Balloon Catheters and PTA Peripheral Drug-Coated Balloon (DCB) Catheters. GlobalData uses proprietary data and analytics to provide a comprehensive report on the pta balloon catheters devices market, including market shares of different players within Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the pta balloon catheters market in Japan was Kaneka followed by Boston Scientific, Becton Dickinson and Co, Medtronic, Koninklijke Philips, Abbott Laboratories, Cook Medical, Lepu Medical Technology (Beijing), Terumo, Shockwave Medical, B. Braun Melsungen, Acotec Scientific and Cordis.
PTA Standard Balloon Catheters are used to open up the arteries that are blocked by plaque build-up (atherosclerosis). A PTA Peripheral DCB Catheters is intended to prevent restenosis, or restenosis of the peripheral arteries.
The value of the pta balloon catheters devices market within Japan was expected to be over $200m in 2023.
For the latest complete market share analysis of pta balloon catheters device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
